Incyte (INCY) Inventory Average (2012 - 2026)
Incyte (INCY) reported Inventory Average of $108.3 million for Q1 2026, up 76.39% on a YoY basis from $61.4 million in Q1 2025, and up 17.47% quarter-over-quarter from $92.2 million in Q4 2025.
Incyte (INCY) Inventory Average (2012 - 2026) Analysis & Trends
Incyte has reported Inventory Average for 15 years, with the latest figure at $108.3 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average rose 76.39% year-over-year to $108.3 million; the trailing twelve-month figure through Mar 2026 stood at $108.3 million (up 76.39% YoY), and the FY2025 full-year result was $80.0 million, up 31.26% from the prior year.
- Inventory Average for Q1 2026 stood at $108.3 million, up from $92.2 million in the prior quarter.
- The five-year high for Inventory Average was $108.3 million in Q1 2026, with the low at $31.7 million in Q1 2022.
- Historically, Inventory Average has averaged $63.1 million across 5 years, with a median of $61.4 million in 2025.
- Annual changes were most pronounced in 2022 — Inventory Average jumped 169.66% — and 2023, when it declined 14.69%.
- Incyte's Inventory Average stood at $43.9 million in 2022, then jumped by 36.77% to $60.1 million in 2023, then gained by 7.61% to $64.7 million in 2024, then soared by 42.65% to $92.2 million in 2025, then gained by 17.47% to $108.3 million in 2026.
- The last three Inventory Average figures came in at $108.3 million (Q1 2026), $92.2 million (Q4 2025), and $83.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 108.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.34 Mn |
| Dec 31, 2025 | 92.23 Mn |
| Sep 30, 2025 | 83.41 Mn |
| Jun 30, 2025 | 73.70 Mn |
| Mar 31, 2025 | 61.42 Mn |
| Dec 31, 2024 | 64.66 Mn |
| Sep 30, 2024 | 85.57 Mn |
| Jun 30, 2024 | 82.15 Mn |
| Mar 31, 2024 | 63.29 Mn |
| Dec 31, 2023 | 60.09 Mn |
| Sep 30, 2023 | 46.55 Mn |
| Jun 30, 2023 | 38.39 Mn |
| Mar 31, 2023 | 41.44 Mn |
| Dec 31, 2022 | 43.93 Mn |
| Sep 30, 2022 | 50.18 Mn |
| Jun 30, 2022 | 45.00 Mn |
| Mar 31, 2022 | 31.70 Mn |
| Dec 31, 2021 | 24.60 Mn |
| Sep 30, 2021 | 18.99 Mn |
| Jun 30, 2021 | 16.69 Mn |